|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| A61K 31/7068 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2326329 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09791127.5 |
| Date of filing the European patent application | 2009-08-04 | |
| (97) | Date of publication of the European application | 2011-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-11 |
| (46) | Date of publication of the claims translation | 2017-05-25 |
| (86) | Number | PCT/US2009/052644 |
| Date | 2009-08-04 |
| (87) | Number | WO 2010/017163 |
| Date | 2010-02-11 |
| (30) | Number | Date | Country code |
| 85913 P | 2008-08-04 | US | |
| 172466 P | 2009-04-24 | US |
| (72) |
WANG, Kenneth, US
ZACHARCHUK, Charles, US
BINLICH, Florence, FR
QUINN, Susan, US
|
| (73) |
Wyeth LLC,
235 East 42nd Street, New York, NY 10017,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 4-Anilin-3-cianochinolinų ir kapecitabino antinavikiniai deriniai |
| Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
| Payment date | Validity (years) | Amount | |
| 2023-07-17 | 15 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-11-16 |